Date of event
-
Continuing Education Credits
CME
ABIM MOC
Add to Calendar 2022-10-01 08:00:00 2022-10-02 12:00:00 2022 Emerging Topic Conference - Controversies and Consensus in Alcohol-Associated Liver Disease Philadelphia, PA United States AASLD alonzo.tolver@boldrstrategy.com America/New_York public

REGISTRATION

Registration to open Wednesday, July 6th at 9am ET!

Course Description/Need Statement

Alcohol-associated liver disease (ALD) is the leading indication for liver related morbidity, mortality and need for liver transplantation. Alcoholic hepatitis (AH) is a severe form of ALD with a high short-term mortality. The AASLD Emerging Topic Conference: Controversies and Consensus in Alcohol-Associated Liver Disease combines the ALD and Liver Transplant Surgery SIGs to develop a combined one and half day program to discuss emerging trends and updates on the disease burden, current treatment options, and future therapies with a focus on updates on early liver transplantation for ALD and AH.

Program Chairs

  • Gene Y. Im, MD
  • Anji Wall, MD, PhD
  • Sumeet K. Asrani, MD, MSc
  • Ashwani K. Singal, MD, MS, FACG, FAASLD

Location

  • Philadelphia Marriott Downtown
    1201 Market Street
    Philadelphia, PA 19107

Continuing Education

  • Continuing Medical Education (CME): 9.50 AMA PRA Category 1 Credits™
  • ABIM MOC points: 9.50 MOC points 

Travel Note

US residents: Please review the Real ID Act regarding boarding federally regulated commercial aircrafts. Due to circumstances resulting from the COVID-19 pandemic, the Department of Homeland Security has extended the REAL ID enforcement deadline to May 3, 2023. Depending on your state of residence, you may need to provide a second form of identification at the airport.

Health and safety information

AASLD is taking steps to protect the health and safety of all stakeholders participating in the Emerging Topic Conference. This meeting will be happening in a public space and AASLD cannot guarantee that participants will not encounter members of the public who have not been fully vaccinated.

AASLD continues to ask all attendees, guests and AASLD staff to follow all applicable regulations and make informed choices about travel, onsite, and external engagement.

AASLD is monitoring the evolving public health guidance and AASLD will continue to update this page as new information becomes available.  AASLD asks all stakeholders to follow all applicable regulations and make informed choices about their participation in one or both in-person conferences offered.

The AASLD Governing Board has approved a “Vaccination Required” policy for all attendees and AASLD staff.

Schedule Note

Breakfast is served at 7:00 am ET both days.

 

Registration Pricing Early Bird: On or Before August 30

Member - $340
Non-Member - $570
Any physician, scientist, or researcher with doctoral-level training who is not employed by Industry (pharma/device/etc.)
Trainee & Associate Member -  $195
Trainee & Associate Non-Member -  $245
Any physician, scientist or researcher in a training program as certified by the director of their training program. This category also includes, but is not limited to, the degrees of MS, NP, PA, RN, and other related or comparable degrees.
Student Member - $95
Student Non-Member - $120
Industry - $815
Any Industry (pharma/device/etc.) employee with or without medical training.
Patient Advocate - $25
Patient Caregiver - $25
Registration scholarships are available by request for the patient advocate and patients and caregivers categories. Please contact Michael Providence, Senior Manager, Patient Engagement at mprovidence@aasld.org for more information.

Registration Pricing: On or After AUGUST 31

Member - $450
Non-Member - $670
Any physician, scientist, or researcher with doctoral-level training who is not employed by Industry (pharma/device/etc.)
Trainee & Associate Member -  $220
Trainee & Associate Non-Member -  $275
Any physician, scientist or researcher in a training program as certified by the director of their training program. This category also includes, but is not limited to, the degrees of MS, NP, PA, RN, and other related or comparable degrees.
Student Member - $110
Student Non-Member - $135
Industry - $920
Any Industry (pharma/device/etc.) employee with or without medical training.
Patient Advocate - $25
Patient Caregiver - $25
Registration scholarships are available by request for the patient advocate and patients and caregivers categories. Please contact Michael Providence, Senior Manager, Patient Engagement at mprovidence@aasld.org for more information.

Registration Cancellation Policy

Requests for cancellations must be submitted in writing to meetings@aasld.org.


Cancellations received by Tuesday, August 30, 2022 will be refunded in full.

Cancellations received between August 31 – September 19, 2022 will be subject to a $50.00 cancellation fee.

Cancellations received on or after September 20, 2022 are not eligible for a refund

Credits Offered

Continuing Medical Education (CME): 9.50 AMA PRA Category 1 Credits™

ABIM Maintenance of Certification (MOC): 9.50 MOC Points 

Accreditation and Designation Statements

Continuing Medical Education (CME) 
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification (MOC) 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.  Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Tuesday, November 15. A link to the CME evaluation will be emailed to attendees after the meeting.

MOC Points 

Physicians seeking ABIM MOC points must complete the CME and MOC evaluation by Tuesday, November 15.  Requests for MOC after this date will not be honored.  The MOC evaluation is included in the CME evaluation. 

MOC Points will be reported to the ABIM by the end of November 2022 for attendees who successfully complete the MOC evaluation. 

Needs Statement

Alcohol-associated liver disease (ALD) is the leading indication for liver related morbidity, mortality and need for liver transplantation. Alcoholic hepatitis (AH) is a severe form of ALD with a high short-term mortality. This ETC combines the ALD and Liver Transplant Surgery SIGs to develop a combined one and half day program to discuss emerging trends and updates on the disease burden, current treatment options, and future therapies with a focus on updates on early liver transplantation for ALD and AH.

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Understand the disease burden of ALD and its current and future pharmacological treatments.  
  • Recognize the unmet need of multidisciplinary care of ALD patients with hepatology and addiction teams.  
  • Understand the status and emerging trends on the role of early liver transplant in patients with life-threatening ALD, including severe AH.

Target Audience

  • Hepatologists    
  • Gastroenterologists    
  • Nurses
  • Nurse Practitioners    
  • Physician Assistants    
  • Transplant Coordinators
  • Surgeons
  • Pharmacists    
  • Fellows/Trainees    
  • Patient Advocacy Groups

This activity was planned in the context of the following ACGME/IOM/IPEC competencies: 
Patient Care and Procedural Skills; Provide Patient-centered Care; Values/Ethics for Interprofessional Practice; Medical Knowledge; Work in Interdisciplinary Teams; Roles/Responsibilities; Practice-based Learning and Improvement; Employ Evidence-based Practice; Interprofessional Communication; Interpersonal and Communication Skills; Apply Quality Improvement; Teams and Teamwork; Professionalism; Utilize Informatics; Systems-based Practice

    

SATURDAY, OCTOBER 1, 2022

Session i: Burden of Alcohol Associated Liver Disease

moderators: Ashwani K. Singal, MD, MS, FACG, FAASLD and Gene Y. Im, MD

  • 8 am – 8:05 am    
    Introduction
    Ashwani K. Singal, MD, MS, FACG, FAASLD
  • 8:05 am – 8:25 am    
    Epidemiology and Cost of AH/ALD Care in U.S.
    Sumeet K. Asrani, MD, MSc
  • 8:25 am – 8:45 am    
    Genetics and Comorbidities in ALD and AUD
    Marsha Y. Morgan, FRCP
  • 8:45 am – 9:05 am    
    Disease Spectrum and Non-invasive Diagnosis of Early ALD
    TBD
  • 9:05 am – 9:25 am    
    Diagnosis of AH
    Deepika Devuni, MBBS
  • 9:25 am – 9:45 am     
    Alcoholic Hepatitis: SIRS, ACLF, and Infections
    Patrick S. Kamath, MD
  • 9:45 am – 10:05 am    
    Panel Discussion/Q&A
  • 10:05 am – 10:30 am    
    Break

SATURDAY, OCTOBER 1, 2022

Session Ii: Prediction and Therapy for AH

moderators: Alex Louvet, MD, PhD and Deepika Devuni, MBBS

  • 10:30 am – 10:50 am     
    Current Therapies of AH 
    Loretta Jophlin, MD, PhD
  • 10:50 am – 11:10 am     
    Emerging and Novel Therapeutic Targets 
    Ashwani K. Singal, MD, MS, FACG, FAASLD
  • 11:10 am – 11:30 am    
    Estimating Prognosis: Current Scores and Biomarkers 
    Allison J. Kwong, MD
  • 11:30 am – 11:50 am    
    Future and Emerging Biomarkers: Diagnosis, Prognosis, and Treatment Response 
    Ramon Bataller, MD, PhD
  • 11:50 am – 12:10 pm    
    Panel Discussion/Q&A
  • 12:10 pm – 1 pm    
    Lunch

SATURDAY, OCTOBER 1, 2022

Session IIi: Management of Alcohol Use Disorder

moderators: TBD and Allison J. Kwong, MD

  • 1 pm – 1:20 pm    
    Management of AUD in Patients with ALD 
    Lamia Haque, MD, MPH
  • 1:20 pm – 1:40 pm    
    Integrating AUD and ALD Care: Multidisciplinary Management with Addiction Specialists 
    Jessica L. Mellinger, MD
  • 1:40 pm – 2 pm    
    Panel Discussion/Q&A
  • 2 pm – 2:20 pm    
    Break

SATURDAY, OCTOBER 1, 2022

Session IV: LT for AH/ALD 

moderators: Sumeet K. Asrani, MD, MSc and Anji Wall, MD, PhD

  • 2:20 pm – 2:40 pm    
    LT in ALD: Unique Pre- and Post-transplant Issues 
    Michael R. Lucey, MD, FAASLD 
  • 2:40 pm – 3 pm    
    Benefits and Current Status of Early LT in AH / ALD 
    Alex Louvet, MD, PhD
  • 3 pm – 3:20 pm    
    LDLT for AH in India and Eastern Countries 
    Mohamed Rela, MBBS, FRCS, DSc
  • 3:20 pm – 3:40 pm    
    Accelerate Consortium: US Experience on Early LT 
    Brian P. Lee, MD
  • 3:40 pm – 4 pm    
    Panel Discussion/Q&A
  • 4 pm – 4:05 pm    
    Wrap-up: Day One
    Gene Y. Im, MD

SUNDAY, OCTOBER , 2022

Session V: Optimizing Candidate Selection in ALD and AH

moderators: Vijay Shah, MD, FAASLD and Michael R. Lucey, MD, FAASLD

  • 8 am – 8:05 am    
    Introduction
    Anji Wall, MD, PhD
  • 8:05 am – 8:25 am     
    Ethical Considerations and Pitfalls of Early LT in AH 
    Anji Wall, MD, PhD
  • 8:25 am – 8:45 am    
    Slippery Slope of Early LT for AH-dangers and Unintended Consequences 
    James F. Trotter, MD
  • 8:45 am – 9:05 am    
    Standardizing Multidisciplinary Care and Patient Selection for LT for AH 
    Norah Terrault, MD, MPH, FAASLD
  • 9:05 am – 9:25 am    
    Panel Discussion/Q&A
  • 9:25 am – 9:45 am     
    Break

SUNDAY, OCTOBER , 2022

Session VI: Next Steps in LT for AH  

moderators: Norah Terrault, MD, MPH, FAASLD and Alex Louvet, MD, PhD

  • 9:45 am – 10:05 am     
    Proposals and Implications for Standard Reporting in UNOS 
    Scott W. Biggins, MD, MAS, FAASLD
  • 10:05 am – 10:25 am     
    Standardizing Post-transplant Monitoring and Management of AUD 
    TBD
  • 10:25 am – 10:45 am     
    Putting it All Together: Clinical Trial Designs 
    Vijay Shah, MD, FAASLD
  • 10:45 am – 11:25 am    
    Putting it All Together: Transplant Committee Simulation: Cases and Consensus 
    Gene Y. Im, MD
  • 11:25 am – 11:45 am    
    Panel Discussion/Q&A
  • 11:45 am – 11:50 am    
    Wrap-up and Adjourn
    Sumeet K. Asrani, MD, MSc

Venue

Philadelphia Marriott Downtown
1201 Market Street 
Philadelphia, PA 19107
Phone: 215-625-2900
*When you are calling to make a reservation, please let the hotel representative know you are attending the AASLD Emerging Topic Conference.

Rates

Single/Double $185 per night plus tax

Cancellation Policy

All hotel room reservations must be cancelled at least 72 hours (local time) in advance to avoid a one-night room penalty.

Airports

•    Philadelphia International Airport (PHL)

Ground Transportation

Shuttle Services

Shuttle services are not provided by the Philadelphia Marriott Downtown hotel. 

Taxi

From PHL the taxi fare estimation is $30.  This estimation is for a one-way fare. 

Metro/Subway/Public Transportation

The estimated metro fare from PHL to the Jefferson Street station is $8. 

Parking

The daily valet parking fee is $57.50. There is limited onsite parking during special events and weekends.